|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.0300 - 2.0300|
|52 Week Range||0.0005 - 60.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for INSD
The Board of Directors of Instadose Pharma Corp., a Nevada corporation, ("Instadose US") announced that effective January 14, 2022, they have accepted the planned resignation of Grant F. Sanders as Chairman and CEO of Instadose US and as Chairman of its wholly owned Canadian subsidiary ("Instadose Canada"). Mr. Sanders will not hold any officer or director positions at Instadose US or Instadose Canada following his resignation.
(OTC PINK: INSD) Instadose Pharma Corp (the "company" or "Instadose") Establishing the world largest continual supply of Medicinal Cannabis. Instadose Pharma Corp is extremely proud to announce the delivery of a record-breaking shipment of high-quality Medicinal Cannabis Flower. The delivery of 2.125 Metric Tons was completed on December 25, 2021, from Johannesburg, South Africa to Skopje, North Macedonia. With this successful delivery it establishes Instadose Pharma Corp as a world leader in th
BOSTON, MA / ACCESSWIRE / December 31, 2021 / Block & Leviton announces that a class action lawsuit has been filed against Instadose Pharma Corp. (OTC: INSD) for potential securities law violations.